OMB Presses Agency Heads For 2013 Budget Reductions
This article was originally published in The Gray Sheet
Executive Summary
White House Office of Management and Budget Director Jack Lew has asked federal agency heads to submit a fiscal 2013 budget request that is at least 5% lower than 2011 funding.
You may also be interested in...
Personalized Medicine Expert Gains Prominent FDA Role In Agency Reorg
Commissioner Margaret Hamburg’s reorganization at the top of FDA puts an expert in pediatric drug development and pharmacogenomics in a new post overseeing four of the seven agency centers, including the device unit.
Big Pharma CEOs Suggest Policy Changes As They Return To Beijing
Global CEOs of J&J, Pfizer, AbbVie and Takeda were among the top pharma executives attending the China Development Forum in its first in-person meeting in three years, and highlighted a number of pharma-related policy changes they would like to see in China. Meanwhile, a Japanese employee of Astellas has been detained in the country for alleged espionage.
For First US OTC Birth Control Application, FDA Extends Time For Advisory Panel Discussion
After postponing planned November advisory committees’ meeting to have time to review more information it requested from sponsor HRA Pharma, FDA sets meeting for 9-10 May. Expanding meeting from one day to a day and a half should allow considering all views and questions about contraceptives.